Challenges in Assessing Survival of In-center vs. Home HD

It’s treatment time that matters, not location—of course—suggests a new thorough review of the survival data. And, while it is challenging to prove a survival benefit when all home HD is so often conflated (short daily vs. nocturnal, for example), quality of life is demonstrably better—and matters more to patients.

Read the abstract » | (added 2019-08-14)

Tags: Treatment Time, Survival Data, Modality, Quality Of Life